PELOSI, NANCY BUYNVDA$500K–$1M—·TUBERVILLE, TOMMY BUYMSFT$50K–$100K—·CRENSHAW, DAN SELLXOM$15K–$50K—·PELOSI, NANCY BUYNVDA$500K–$1M—·TUBERVILLE, TOMMY BUYMSFT$50K–$100K—·CRENSHAW, DAN SELLXOM$15K–$50K—·
← Leaderboard
SYNH
Ticker

SYNH

Congressional Trades
1
by 1 members
Buys
0
0%
Sells
0
0%
Total Volume
$8K
midpoint
Unique Traders
1
members

Party Breakdown

Democrats1 · 100%
Republicans0 · 0%

💼 Lobbying Filings

all →
  • 2026-04-20$30K
    SYNEOS HEALTH INC.
    Clinical trials and research. Remote clinical trials, biomedical research & development. Business and corporate tax issues, international tax reform; including international minimum tax proposals; issues related to research and development.
  • 2026-01-20$30K
    SYNEOS HEALTH INC.
    Clinical trials and research. Remote clinical trials, biomedical research & development. Business and corporate tax issues, international tax reform; including international minimum tax proposals; issues related to research and development.
  • 2025-10-20$30K
    SYNEOS HEALTH INC.
    Business and corporate tax issues, international tax reform; including international minimum tax proposals; issues related to research and development. Clinical trials and research. Remote clinical trials, biomedical research & development.
  • 2025-07-21$30K
    SYNEOS HEALTH INC.
    Clinical trials and research. Remote clinical trials, biomedical research & development. Business and corporate tax issues, international tax reform; including international minimum tax proposals; issues related to research and development.
  • 2025-04-21$30K
    SYNEOS HEALTH INC.
    Clinical trials and research. Remote clinical trials, biomedical research & development, issues related to diversity in clinical trials. Business and corporate tax issues, international tax reform; including international minimum tax proposals; issues related to research and development.
  • 2025-01-22$30K
    SYNEOS HEALTH INC.
    Clinical trials and research. Remote clinical trials, biomedical research & development, issues related to diversity in clinical trials. Business and corporate tax issues, international tax reform; including international minimum tax proposals; issues related to research and development.

Congressional Momentum

buy vs. sell pressureDISTRIBUTING

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days
No trades
Last 90 Days
No trades
All-Time
▼0
0 buys1 total1 sell
$0 buys · $8K sells

All Disclosed Trades

DateMemberActionAmountFiling Delay
2022-12-06DJosh GottheimerPARTIAL_SELL$1K – $15K29d